Shanghai Pharmaceuticals Holding Co. Ltd.SSE: 601607

Announcement on Obtaining Approval for Production of Tofacitinib Citrate Sustained-Release Tablets

· Issued by Shanghai Pharmaceuticals Holding Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Shanghai Pharmaceuticals Holding Co. Ltd. has announced that its subsidiary has received approval for the production of Tofacitinib Citrate Sustained-Release Tablets from the National Medical Products Administration.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining Approval for Production of Tofacitinib Citrate Sustained-Release Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shanghai Pharmaceuticals Holding Co. Ltd. on 6ix

Earlier from Shanghai Pharmaceuticals

Later from Shanghai Pharmaceuticals

All Shanghai Pharmaceuticals news releases